Evidence map›Paper›PMID 31311198›Full record

ArticleCells2019

Human Platelet Lysate as a Functional Substitute for Fetal Bovine Serum in the Culture of Human Adipose Derived Stromal/Stem Cells.

Mathew Cowper, Trivia Frazier, Xiying Wu, Lowry Curley, Michelle H Ma, Omair A Mohiuddin, Marilyn Dietrich, Michelle McCarthy, Joanna Bukowska, Jeffrey M Gimble

Abstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. In Vitro and Ectopic In Vivo Studies toward the Utilization ofInternational journal of molecular sciences · 2022
    Article
  8. Posology and Serum-/Xeno-Free Engineered Adipose Stromal Cells Cell Sheets.Frontiers in cell and developmental biology · 2022
    Article
  9. Article
  10. Article
  11. Human platelet lysate - A potent (and overlooked) orthobiologic.Journal of clinical orthopaedics and trauma · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mathew CowperSchool of Medicine, Tulane University, New Orleans, LA 70112, USA.
Trivia FrazierSchool of Medicine, Tulane University, New Orleans, LA 70112, USA.
Xiying WuLaCell LLC, New Orleans, LA 70148, USA.
Lowry CurleyLaCell LLC, New Orleans, LA 70148, USA.
Michelle H MaObatala Sciences Inc., New Orleans, LA 70148, USA.
Omair A MohiuddinSchool of Medicine, Tulane University, New Orleans, LA 70112, USA.
Marilyn DietrichLouisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803, USA.
Michelle McCarthySchool of Medicine, Tulane University, New Orleans, LA 70112, USA.
Joanna BukowskaSchool of Medicine, Tulane University, New Orleans, LA 70112, USA.
Jeffrey M GimbleSchool of Medicine, Tulane University, New Orleans, LA 70112, USA. jeffrey.gimble@lacell-usa.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; however, many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement. The current study explores the substitution of lysates from expired human platelets (HPLs) as an FBS substitute.

methodsExpired human platelets from an authorized blood center were lysed by freeze/thawing and used to examine human ASCs with respect to proliferation using hematocytometer cell counts, colony forming unit-fibroblast (CFU-F) frequency, surface immunophenotype by flow cytometry, and tri-lineage (adipocyte, chondrocyte, osteoblast) differentiation potential by histochemical staining.

resultsThe proliferation assays demonstrated that HPLs supported ASC proliferation in a concentration dependent manner, reaching levels that exceeded that observed in the presence of 10% FBS. The concentration of 0.75% HPLs was equivalent to 10% FBS when utilized in cell culture media with respect to proliferation, immunophenotype, and CFU-F frequency. When added to osteogenic, adipogenic, and chondrogenic differentiation media, both supplements showed appropriate differentiation by staining.

conclusionHPLs is an effective substitute for FBS in the culture, expansion and differentiation of human ASCs suitable for pre-clinical studies; however, additional assays and analyses will be necessary to validate HPLs for clinical applications and regulatory approval.

Indexed as

Cell DifferentiationAdipose TissueAnimalsBlood PlateletsCattleCell ProliferationCells, CulturedCulture Media, Serum-FreeHumansMesenchymal Stem CellsSerumCulture Media, Serum-Freeadipogenesisadipose-derived stromal/stem cellschondrogenesiscolony forming unit-fibroblastfetal bovine serumhuman platelet lysatemesenchymal stem cellosteogenesisregenerative medicine

Identifiers

PMID31311198
PMCPMC6679214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.